Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001949455 | SCV002245997 | pathogenic | Supravalvar aortic stenosis | 2022-03-26 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ELN-related conditions. For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu56Trpfs*66) in the ELN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ELN are known to be pathogenic (PMID: 11175284). |
Fulgent Genetics, |
RCV002484807 | SCV002782806 | likely pathogenic | Cutis laxa, autosomal dominant 1; Williams syndrome; Supravalvar aortic stenosis | 2022-02-22 | criteria provided, single submitter | clinical testing |